Randomized Controlled Trial to Evaluate the Effect of a Cognitive Behavioral Program and Resilient Model in the Treatment of Depression and Anxiety and Impact on the Quality of Life in End-Stage Renal Disease Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- End-Stage Renal Disease
- Sponsor
- Hospital Civil de Guadalajara
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Quality of Life Perception (change is being assessed from baseline depression, at 8 weeks and after 5 weeks).
- Last Updated
- 7 years ago
Overview
Brief Summary
This study evaluates the effect of a single cognitive-behavioral intervention (CBI) in a control group against the same CBI plus the strengthening of resiliency skills in an experimental group, on ESRD patients.
Detailed Description
Cognitive behavioral therapy has long been an alternative in the treatment of symptoms of depression and anxiety in patients with chronic diseases such as renal failure, however the combination of therapeutic approaches that include not only pathological but also another more positive approach (as the resilient model), represents a novel proposal for the treatment of negative psychological symptoms and improvement of the quality of life in these patients. The inclusion of the resilient model in a cognitive behavioral intervention serves as a possibility of therapeutic target that could enhance the effectiveness of the treatment.
Investigators
Cristina Jazmin Gonzalez Flores
Principal Investigator
Hospital Civil de Guadalajara
Eligibility Criteria
Inclusion Criteria
- •Older than 18, and younger than 61 years old
- •Depression score in the Beck Depression Inventory (BDI) greater than 30 points.
- •Anxiety score in the Beck Anxiety Inventory (BAI) greater than 40 points.
- •Have not been hospitalized over the last 6 months
- •Signing of informed consent
Exclusion Criteria
- •May not be able to communicate in the Spanish language.
- •Presence of psychiatric comorbidity (suicide ideation or depressive or anxious).
Outcomes
Primary Outcomes
Quality of Life Perception (change is being assessed from baseline depression, at 8 weeks and after 5 weeks).
Time Frame: From Baseline, at 8 weeks for the intervention phase, and 5 weeks of following.
Outcome measuring will be held at the baseline, after finishing the intervention (8 weeks), and after a following period of 5 weeks. Tool: Kidney Disease Quality of life (KDQOL 36)